Shandong Wohua Pharmaceutical Co Ltd (002107) — Cash Flow-to-Debt Ratio
Shandong Wohua Pharmaceutical Co Ltd (002107) has a Cash Flow-to-Debt Ratio of 0.10x as of June 2025, meaning its operating cash flow of CN¥27.12 Million could theoretically repay 0% of its total liabilities (CN¥280.66 Million) in one year. Check Shandong Wohua Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Wohua Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Shandong Wohua Pharmaceutical Co Ltd across 23 annual periods. Also explore Shandong Wohua Pharmaceutical Co Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Shandong Wohua Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Shandong Wohua Pharmaceutical Co Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.50x | CN¥128.53 Million | CN¥256.47 Million | ▲ +43.9% |
| 2024 | 0.35x | CN¥91.51 Million | CN¥262.80 Million | ▼ -16.1% |
| 2023 | 0.42x | CN¥129.25 Million | CN¥311.23 Million | ▼ -30.5% |
| 2022 | 0.60x | CN¥185.26 Million | CN¥310.20 Million | ▼ -30.8% |
| 2021 | 0.86x | CN¥200.12 Million | CN¥231.83 Million | ▲ +98.5% |
| 2020 | 0.43x | CN¥196.58 Million | CN¥452.08 Million | ▲ +219.9% |
| 2019 | 0.14x | CN¥31.66 Million | CN¥232.87 Million | ▼ -71.4% |
| 2018 | 0.48x | CN¥107.88 Million | CN¥226.60 Million | ▼ -23.2% |
| 2017 | 0.62x | CN¥123.88 Million | CN¥199.71 Million | ▲ +13.1% |
| 2016 | 0.55x | CN¥72.91 Million | CN¥132.99 Million | ▼ -50.1% |
| 2015 | 1.10x | CN¥132.82 Million | CN¥120.97 Million | ▲ +52.4% |
| 2014 | 0.72x | CN¥26.58 Million | CN¥36.89 Million | ▲ +90.2% |
| 2013 | 0.38x | CN¥15.15 Million | CN¥40.01 Million | ▼ -44.9% |
| 2012 | 0.69x | CN¥33.86 Million | CN¥49.28 Million | ▲ +1729.9% |
| 2011 | 0.04x | CN¥1.36 Million | CN¥36.28 Million | ▲ +111.2% |
| 2010 | -0.34x | CN¥-15.28 Million | CN¥45.49 Million | ▼ -35.1% |
| 2009 | -0.25x | CN¥-21.24 Million | CN¥85.41 Million | ▼ -151.9% |
| 2008 | 0.48x | CN¥35.59 Million | CN¥74.23 Million | ▲ +405.8% |
| 2007 | 0.09x | CN¥10.46 Million | CN¥110.32 Million | ▼ -80.6% |
| 2006 | 0.49x | CN¥46.05 Million | CN¥94.44 Million | ▲ +214.4% |
| 2005 | 0.16x | CN¥13.01 Million | CN¥83.88 Million | ▼ -67.7% |
| 2004 | 0.48x | CN¥33.77 Million | CN¥70.30 Million | ▲ +120.1% |
| 2003 | 0.22x | CN¥18.17 Million | CN¥83.28 Million | — |